Statistics for Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)
Total visits
| views | |
|---|---|
| Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS) | 72 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:9860de1c-1d4d-48a2-a5df-406325b1dc86 | 38 |
| 12885_2021_Article_8085.pdf | 28 |
| java.util.UUID:24f7beca-71ca-4dd9-a7c2-f0661acdd693 | 15 |
| java.util.UUID:2aee9014-3974-4001-a550-15efd4c0615b | 9 |
Top country views
| views | |
|---|---|
| United States | 65 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 46 |
| Houston | 7 |
| Mount Laurel | 4 |
| Cambridge | 2 |
| Fairfield | 2 |
| Ann Arbor | 1 |
| Franklin | 1 |
| Lake Mary | 1 |
| Seremban | 1 |